Shopping Cart
Remove All
Your shopping cart is currently empty
PW507 is a potent, blood-brain barrier penetrable, and selective sigma 1 receptor (S1R) antagonist with a Ki value of 7.5 nM against human S1R. It exhibits lower binding affinity for S2R and hERG. This compound is utilized in the study of painful diabetic neuropathy (PDN).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | PW507 is a potent, blood-brain barrier penetrable, and selective sigma 1 receptor (S1R) antagonist with a Ki value of 7.5 nM against human S1R. It exhibits lower binding affinity for S2R and hERG. This compound is utilized in the study of painful diabetic neuropathy (PDN). |
| In vitro | PW507 binds to the orthosteric site of the human S1R crystal structure and engages in strong interactions with the receptor. |
| In vivo | PW507 (20 mg/kg; intraperitoneal injection; twice daily; for 14 days) demonstrated significant therapeutic efficacy in alleviating mechanical allodynia. |
| Molecular Weight | 334.89 |
| Formula | C18H27ClN4 |
| Cas No. | 2573850-59-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.